Detalhe da pesquisa
1.
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.
Lancet HIV
; 5(12): e715-e722, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30527329
2.
Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.
J Allergy Clin Immunol
; 112(5): 973-80, 2003 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-14610491